MENU
+Compare
DRRX
Stock ticker: NASDAQ
AS OF
Aug 29, 04:59 PM (EDT)
Price
$1.93
Change
-$0.02 (-1.03%)
Capitalization
60.25M

DRRX DURECT Corp Forecast, Technical & Fundamental Analysis

Durect Corp is a biopharmaceutical company... Show more

DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DRRX with price predictions
Aug 28, 2025

DRRX in upward trend: price rose above 50-day moving average on July 29, 2025

DRRX moved above its 50-day moving average on July 29, 2025 date and that indicates a change from a downward trend to an upward trend. In of 41 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 14, 2025. You may want to consider a long position or call options on DRRX as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The 10-day moving average for DRRX crossed bullishly above the 50-day moving average on July 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for DRRX moved above the 200-day moving average on August 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DRRX advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for DRRX turned negative on August 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DRRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DRRX broke above its upper Bollinger Band on August 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for DRRX entered a downward trend on July 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DRRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.301) is normal, around the industry mean (17.318). P/E Ratio (0.000) is within average values for comparable stocks, (73.434). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.903). DRRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (36.364) is also within normal values, averaging (41.941).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DRRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products for pain and chronic diseases

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
10240 Bubb Road
Phone
+1 408 777-1417
Employees
58
Web
https://www.durect.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRPTF19.28N/A
N/A
Getlink SE
PRKWF3.37N/A
N/A
Parkway Life REIT
PROM1.20N/A
N/A
Propel Media, Inc.
KSTOF2.35N/A
N/A
KISTOS HOLDINGS PLC
IVAUF11.01N/A
N/A
Investcorp AI Acquisition Corp.

DRRX and Stocks

Correlation & Price change

A.I.dvisor tells us that DRRX and UPC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DRRX and UPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRRX
1D Price
Change %
DRRX100%
+0.52%
UPC - DRRX
27%
Poorly correlated
-3.53%
SNDL - DRRX
24%
Poorly correlated
+6.32%
OGI - DRRX
22%
Poorly correlated
+3.59%
ACB - DRRX
22%
Poorly correlated
+5.44%
ZOMDF - DRRX
22%
Poorly correlated
+0.24%
More

Groups containing DRRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRRX
1D Price
Change %
DRRX100%
+0.52%
Pharmaceuticals: Generic
industry (224 stocks)
6%
Poorly correlated
-0.14%